Erytech Pharma S.A. buy tbackenh
Start price
26.09.16
/
50%
€19.25
Target price
27.03.17
€22.00
Performance (%)
-25.71%
End price
27.03.17
€14.30
Summary
This prediction ended on 27.03.17 with a price of €14.30. The price of Erytech Pharma S.A. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -25.71%. tbackenh has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Erytech Pharma S.A. | - | - | - | - |
| iShares Core DAX® | -0,20 % | 5,47 % | 9,19 % | 48,66 % |
| iShares Nasdaq 100 | 2,57 % | 10,09 % | 39,29 % | 95,72 % |
| iShares Nikkei 225® | 0,60 % | 9,87 % | 46,20 % | 63,77 % |
| iShares S&P 500 | 1,80 % | 7,40 % | 29,62 % | 67,24 % |
Comments by tbackenh for this prediction
In the thread Erytech Pharma S.A. diskutieren
Erytech Pharma S.A.
Phase 2 eines Bauchspeicheldrüsenkrebsmedikamentes erfolgreich abgeschlossen, könnte 2017 richtig abgehen.
(Laufzeit überschritten)
Stopped prediction by tbackenh for Erytech Pharma S.A.
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€28.20
31.03.17
31.03.17
€32.00
02.10.17
02.10.17
-17.59%
02.10.17
02.10.17
